Therapeutic strategies to overcome ALK resistance in cancer /
"Therapeutic Strategies to Overcome ALK Resistance in Cancer, Volume 13, presents current strategies to improve and prolong clinical benefit in ALK driven cancers. Most patients with ALK-driven cancer are sensitive to tyrosine kinase inhibitor (TKI) therapy, but resistance invariably develops....
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | eBook |
| Language: | English |
| Published: |
London, United Kingdom :
Academic Press, an imprint of Elsevier,
[2021]
|
| Series: | Cancer sensitizing agents for chemotherapy ;
v. 13. |
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Internet
Connect to the full text of this electronic bookAvailable Online
| Call Number: |
RC280.L8 |
|
|---|---|---|
| Call Number | Status | Get It |
| RC280.L8 | Available | |